相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Genetic editing of colonic organoids provides a molecularly distinct and orthotopic preclinical model of serrated carcinogenesis
Tamsin R. M. Lannagan et al.
GUT (2019)
Phase Ib with expansion study of olaparib plus weekly (Metronomic) carboplatin and paclitaxel in relapsed ovarian cancer patients
Saul Eugene Rivkin et al.
INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER (2019)
Therapeutic Targeting of Collective Invasion in Ovarian Cancer
Laura Moffitt et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2019)
Epithelial ovarian cancer: Evolution of management in the era of precision medicine
Stephanie Lheureux et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2019)
Combination of niraparib and bevacizumab versus niraparib alone as treatment of recurrent platinum-sensitive ovarian cancer: A randomized controlled chemotherapy-free study-NSGO-AVANOVA2/ENGOT-OV24.
Mansoor Raza Mirza et al.
JOURNAL OF CLINICAL ONCOLOGY (2019)
An organoid platform for ovarian cancer captures intra- and interpatient heterogeneity
Oded Kopper et al.
NATURE MEDICINE (2019)
Immunogenicity of Tumor Initiating Stem Cells: Potential Applications in Novel Anticancer Therapy
Durga Khandekar et al.
FRONTIERS IN ONCOLOGY (2019)
Oral metronomic cyclophosphamide in advanced ovarian cancer: long-lasting clinical response in an elderly frailty patient
Michela Villa et al.
ANTI-CANCER DRUGS (2019)
Loss of PTEN in Fallopian Tube Epithelium Results in Multicellular Tumor Spheroid Formation and Metastasis to the Ovary
Matthew Dean et al.
CANCERS (2019)
The Role of Intra-Tumoral Heterogeneity and Its Clinical Relevance in Epithelial Ovarian Cancer Recurrence and Metastasis
Cai M. Roberts et al.
CANCERS (2019)
Veliparib with First-Line Chemotherapy and as Maintenance Therapy in Ovarian Cancer
R. L. Coleman et al.
NEW ENGLAND JOURNAL OF MEDICINE (2019)
Mitochondrial fission causes cisplatin resistance under hypoxic conditions via ROS in ovarian cancer cells
Youngjin Han et al.
ONCOGENE (2019)
FAK activity sustains intrinsic and acquired ovarian cancer resistance to platinum chemotherapy
Carlos J. Diaz Osterman et al.
ELIFE (2019)
Keratin-14 (KRT14) Positive Leader Cells Mediate Mesothelial Clearance and Invasion by Ovarian Cancer Cells
Maree Bilandzic et al.
CANCERS (2019)
Linking stemness with colorectal cancer initiation, progression, and therapy
Deepak Narayanan Iyer et al.
WORLD JOURNAL OF STEM CELLS (2019)
Magmas inhibition as a potential treatment strategy in malignant glioma
Kaijun Di et al.
JOURNAL OF NEURO-ONCOLOGY (2019)
PARP Inhibition Induces Enrichment of DNA Repair-Proficient CD133 and CD117 Positive Ovarian Cancer Stem Cells
Chiara Bellio et al.
MOLECULAR CANCER RESEARCH (2019)
Poly(ADP-Ribose) Polymerase Inhibition Sensitizes Colorectal Cancer-Initiating Cells to Chemotherapy
Awad Jarrar et al.
STEM CELLS (2019)
Engineering Precision Medicine
Wujin Sun et al.
ADVANCED SCIENCE (2019)
A simple high-throughput approach identifies actionable drug sensitivities in patient-derived tumor organoids
Nhan Phan et al.
COMMUNICATIONS BIOLOGY (2019)
Targeting of lipid metabolism with a metabolic inhibitor cocktail eradicates peritoneal metastases in ovarian cancer cells
Rain R. Chen et al.
COMMUNICATIONS BIOLOGY (2019)
Epigenetics in ovarian cancer
Yanina Natanzon et al.
SEMINARS IN CANCER BIOLOGY (2018)
Detachment from the primary site and suspension in ascites as the initial step in metabolic reprogramming and metastasis to the omentum in ovarian cancer
Masakazu Sato et al.
ONCOLOGY LETTERS (2018)
Paclitaxel-Loaded Self-Assembled Lipid Nanoparticles as Targeted Drug Delivery Systems for the Treatment of Aggressive Ovarian Cancer
Jiali Zhai et al.
ACS APPLIED MATERIALS & INTERFACES (2018)
Circulating tumor cell-derived organoids: Current challenges and promises in medical research and precision medicine
Prakash P. Praharaj et al.
BIOCHIMICA ET BIOPHYSICA ACTA-REVIEWS ON CANCER (2018)
Cancer Statistics, 2018
Rebecca L. Siegel et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2018)
A Living Biobank of Breast Cancer Organoids Captures Disease Heterogeneity
Norman Sachs et al.
CELL (2018)
Tumor Evolution and Drug Response in Patient-Derived Organoid Models of Bladder Cancer
Suk Hyung Lee et al.
CELL (2018)
Targeting Breast Cancer Stem Cell State Equilibrium through Modulation of Redox Signaling
Ming Luo et al.
CELL METABOLISM (2018)
JAK/STAT3-Regulated Fatty Acid β-Oxidation Is Critical for Breast Cancer Stem Cell Self-Renewal and Chemoresistance
Tianyi Wang et al.
CELL METABOLISM (2018)
FORWARD I: a Phase III study of mirvetuximab soravtansine versus chemotherapy in platinum-resistant ovarian cancer
Kathleen N. Moore et al.
FUTURE ONCOLOGY (2018)
Quality of life in patients with recurrent ovarian cancer treated with niraparib versus placebo (ENGOT-OV16/NOVA): results from a double-blind, phase 3, randomised controlled trial
Amit M. Oza et al.
LANCET ONCOLOGY (2018)
Health-related quality of life and patient-centred outcomes with olaparib maintenance after chemotherapy in patients with platinum-sensitive, relapsed ovarian cancer and a BRCA1/2 mutation (SOLO2/ENGOT Ov-21): a placebo-controlled, phase 3 randomised trial
Michael Friedlander et al.
LANCET ONCOLOGY (2018)
Toxicity of Doxorubicin (Dox) to different experimental organ systems
Arivalagan Pugazhendhi et al.
LIFE SCIENCES (2018)
PTEN loss in the fallopian tube induces hyperplasia and ovarian tumor formation
Angela Russo et al.
ONCOGENE (2018)
Fluid shear stress impacts ovarian cancer cell viability, subcellular organization, and promotes genomic instability
Alexandra R. Hyler et al.
PLOS ONE (2018)
Prognostic factors in epithelial ovarian cancer: A population-based study
Lin-Chau Chang et al.
PLOS ONE (2018)
Systemic surfaceome profiling identifies target antigens for immune-based therapy in subtypes of advanced prostate cancer
John K. Lee et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2018)
Patient-derived organoids model treatment response of metastatic gastrointestinal cancers
Georgios Vlachogiannis et al.
SCIENCE (2018)
Patient-derived tumor organoids for prediction of cancer treatment response
Peter W. Nagle et al.
SEMINARS IN CANCER BIOLOGY (2018)
ROS signalling in the biology of cancer
Jennifer N. Moloney et al.
SEMINARS IN CELL & DEVELOPMENTAL BIOLOGY (2018)
Momelotinib decreased cancer stem cell associated tumor burden and prolonged disease-free remission period in a mouse model of human ovarian cancer
Emily Chan et al.
Oncotarget (2018)
Immune Curbing of Cancer Stem Cells by CTLs Directed to NANOG
Christina Wefers et al.
FRONTIERS IN IMMUNOLOGY (2018)
Cancer Stem Cell Metabolism and Potential Therapeutic Targets
Vusala Snyder et al.
FRONTIERS IN ONCOLOGY (2018)
Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries
Freddie Bray et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2018)
Generation of Tumor-Reactive T Cells by Co-culture of Peripheral Blood Lymphocytes and Tumor Organoids
Krijn K. Dijkstra et al.
CELL (2018)
Prediction of DNA Repair Inhibitor Response in Short-Term Patient-Derived Ovarian Cancer Organoids
Sarah J. Hill et al.
CANCER DISCOVERY (2018)
Tumor immunotherapy-the potential of epigenetic drugs to overcome resistance
Camilla M. Grunewald et al.
TRANSLATIONAL CANCER RESEARCH (2018)
Regulation of Ovarian Cancer Prognosis by Immune Cells in the Tumor Microenvironment
Maureen L. Drakes et al.
CANCERS (2018)
Can Stemness and Chemoresistance Be Therapeutically Targeted via Signaling Pathways in Ovarian Cancer?
Lynn Roy et al.
CANCERS (2018)
Epigenetic Crosstalk between the Tumor Microenvironment and Ovarian Cancer Cells: A Therapeutic Road Less Traveled
Yuliya Klymenko et al.
CANCERS (2018)
Targeting the Microenvironment in High Grade Serous Ovarian Cancer
Nkechiyere G. Nwani et al.
CANCERS (2018)
Tumour microenvironment and metabolic plasticity in cancer and cancer stem cells: Perspectives on metabolic and immune regulatory signatures in chemoresistant ovarian cancer stem cells
Nuzhat Ahmed et al.
SEMINARS IN CANCER BIOLOGY (2018)
Molecular Mechanisms Regulating Organ-Specific Metastases in Epithelial Ovarian Carcinoma
Maria V. Barbolina
CANCERS (2018)
Patient-derived organoids: a promising model for personalized cancer treatment
Huayu Yang et al.
GASTROENTEROLOGY REPORT (2018)
CD133 Promotes Adhesion to the Ovarian Cancer Metastatic Niche
Lynn Roy et al.
CANCER GROWTH AND METASTASIS (2018)
Tumor is an Oxidative Stress Factor in Ovarian Cancer Patients
Oana Trifanescu et al.
CHIRURGIA (2018)
Fifth Ovarian Cancer Consensus Conference of the Gynecologic Cancer InterGroup: recurrent disease
M. K. Wilson et al.
ANNALS OF ONCOLOGY (2017)
International patterns and trends in ovarian cancer incidence, overall and by histologic subtype
S. B. Coburn et al.
INTERNATIONAL JOURNAL OF CANCER (2017)
A Combination of Immune Checkpoint Inhibition with Metronomic Chemotherapy as a Way of Targeting Therapy-Resistant Cancer Cells
Irina Kareva
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2017)
Safety and Activity of Mirvetuximab Soravtansine (IMGN853), a Folate Receptor Alpha-Targeting Antibody-Drug Conjugate, in Platinum-Resistant Ovarian, Fallopian Tube, or Primary Peritoneal Cancer: A Phase I Expansion Study
Kathleen N. Moore et al.
JOURNAL OF CLINICAL ONCOLOGY (2017)
Rucaparib maintenance treatment for recurrent ovarian carcinoma after response to platinum therapy (ARIEL3): a randomised, double-blind, placebo-controlled, phase 3 trial
Robert L. Coleman et al.
LANCET (2017)
Rucaparib in relapsed, platinum-sensitive high-grade ovarian carcinoma (ARIEL2 Part 1): an international, multicentre, open-label, phase 2 trial
Elizabeth M. Swisher et al.
LANCET ONCOLOGY (2017)
Olaparib tablets as maintenance therapy in patients with platinum-sensitive, relapsed ovarian cancer and a BRCA1/2 mutation (SOLO2/ENGOT-Ov21): a double-blind, randomised, placebo-controlled, phase 3 trial
Eric Pujade-Lauraine et al.
LANCET ONCOLOGY (2017)
Screening drug effects in patient-derived cancer cells links organoid responses to genome alterations
Julia Jabs et al.
MOLECULAR SYSTEMS BIOLOGY (2017)
Human primary liver cancer-derived organoid cultures for disease modeling and drug screening
Laura Broutier et al.
NATURE MEDICINE (2017)
Use of CRISPR-modified human stem cell organoids to study the origin of mutational signatures in cancer
Jarno Drost et al.
SCIENCE (2017)
PD-1 and PD-L1 Checkpoint Signaling Inhibition for Cancer Immunotherapy: Mechanism, Combinations, and Clinical Outcome
Hashem O. Alsaab et al.
FRONTIERS IN PHARMACOLOGY (2017)
Dose-Response Association of CD8+ Tumor-Infiltrating Lymphocytes and Survival Time in High-Grade Serous Ovarian Cancer
Ellen L. Goode et al.
JAMA ONCOLOGY (2017)
The disparate origins of ovarian cancers: pathogenesis and prevention strategies
Anthony N. Karnezis et al.
NATURE REVIEWS CANCER (2017)
NF-κB Participates in the Stem Cell Phenotype of Ovarian Cancer Cells
Carolina Gonzalez-Torres et al.
ARCHIVES OF MEDICAL RESEARCH (2017)
Epigenetic therapy for the treatment of epithelial ovarian cancer: A clinical review
Haller J. Smith et al.
GYNECOLOGIC ONCOLOGY REPORTS (2017)
Fifth Ovarian Cancer Consensus Conference of the Gynecologic Cancer InterGroup: first-line interventions
A. Karam et al.
ANNALS OF ONCOLOGY (2017)
Fifth Ovarian Cancer Consensus Conference: individualized therapy and patient factors
J. McGee et al.
ANNALS OF ONCOLOGY (2017)
Clinical response in patients with ovarian cancer treated with metronomic chemotherapy
Herman Andres Perroud et al.
ECANCERMEDICALSCIENCE (2017)
Lipid Desaturation Is a Metabolic Marker and Therapeutic Target of Ovarian Cancer Stem Cells
Junjie Li et al.
CELL STEM CELL (2017)
Tumor-Derived Cell Lines as Molecular Models of Cancer Pharmacogenomics
Andrew Goodspeed et al.
MOLECULAR CANCER RESEARCH (2016)
A Three-Dimensional Organoid Culture System Derived from Human Glioblastomas Recapitulates the Hypoxic Gradients and Cancer Stem Cell Heterogeneity of Tumors Found In Vivo
Christopher G. Hubert et al.
CANCER RESEARCH (2016)
Systematic evaluation of multiple immune markers reveals prognostic factors in ovarian cancer
Phillip P. Santoiemma et al.
GYNECOLOGIC ONCOLOGY (2016)
Tumor-Associated Macrophages and Myeloid-Derived Suppressor Cells as Immunosuppressive Mechanism in Ovarian Cancer Patients: Progress and Challenges
Karolina Okla et al.
INTERNATIONAL REVIEWS OF IMMUNOLOGY (2016)
Metronomic chemotherapy prevents therapy-induced stromal activation and induction of tumor-initiating cells
Tze-Sian Chan et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2016)
In vitro and in vivo correlates of physiological and neoplastic human Fallopian tube stem cells
Yusuke Yamamoto et al.
JOURNAL OF PATHOLOGY (2016)
Overall survival in patients with platinum-sensitive recurrent serous ovarian cancer receiving olaparib maintenance monotherapy: an updated analysis from a randomised, placebo-controlled, double-blind, phase 2 trial
Jonathan A. Ledermann et al.
LANCET ONCOLOGY (2016)
Vascular bursts enhance permeability of tumour blood vessels and improve nanoparticle delivery
Yu Matsumoto et al.
NATURE NANOTECHNOLOGY (2016)
Niraparib Maintenance Therapy in Platinum-Sensitive, Recurrent Ovarian Cancer
M. R. Mirza et al.
NEW ENGLAND JOURNAL OF MEDICINE (2016)
Omentum and bone marrow: how adipocyte-rich organs create tumour microenvironments conducive for metastatic progression
H. Chkourko Gusky et al.
OBESITY REVIEWS (2016)
New models of hematogenous ovarian cancer metastasis demonstrate preferential spread to the ovary and a requirement for the ovary for abdominal dissemination
Lan G. Coffman et al.
TRANSLATIONAL RESEARCH (2016)
Genomics of Ovarian Cancer Progression Reveals Diverse Metastatic Trajectories Including Intraepithelial Metastasis to the Fallopian Tube
Mark A. Eckert et al.
CANCER DISCOVERY (2016)
Aldehyde dehydrogenase 1A1 in stem cells and cancer
Hiroyuki Tomita et al.
ONCOTARGET (2016)
Unique proteome signature of post-chemotherapy ovarian cancer ascites-derived tumor cells
Nuzhat Ahmed et al.
SCIENTIFIC REPORTS (2016)
Aldehyde dehydrogenases in cancer stem cells: potential as therapeutic targets
David W. Clark et al.
ANNALS OF TRANSLATIONAL MEDICINE (2016)
Metronomic chemotherapy: An attractive alternative to maximum tolerated dose therapy that can activate anti-tumor immunity and minimize therapeutic resistance
Irina Kareva et al.
CANCER LETTERS (2015)
Prospective Derivation of a Living Organoid Biobank of Colorectal Cancer Patients
Marc van de Wetering et al.
CELL (2015)
Organoid Models of Human and Mouse Ductal Pancreatic Cancer
Sylvia F. Boj et al.
CELL (2015)
Two Types of Ovarian Cortical Inclusion Cysts: Proposed Origin and Possible Role in Ovarian Serous Carcinogenesis
Natalie Banet et al.
INTERNATIONAL JOURNAL OF GYNECOLOGICAL PATHOLOGY (2015)
Germline Mutations in the BRIP1, BARD1, PALB2, and NBN Genes in Women With Ovarian Cancer
Susan J. Ramus et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2015)
Modeling colorectal cancer using CRISPR-Cas9-mediated engineering of human intestinal organoids
Mami Matano et al.
NATURE MEDICINE (2015)
The Notch and Wnt pathways regulate stemness and differentiation in human fallopian tube organoids
Mirjana Kessler et al.
NATURE COMMUNICATIONS (2015)
LAG3 and PD1 co-inhibitory molecules collaborate to limit CD8+ T cell signaling and dampen antitumor immunity in a murine ovarian cancer model
Ruea-Yea Huang et al.
ONCOTARGET (2015)
Germline Mutations in the BRIP1, BARD1, PALB2, and NBN Genes in Women With Ovarian Cancer
Susan J. Ramus et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2015)
PI3K/AKT/mTOR signaling pathway as a therapeutic target for ovarian cancer
HaiXia Li et al.
ARCHIVES OF GYNECOLOGY AND OBSTETRICS (2014)
Inhibition of the JAK2/STAT3 pathway in ovarian cancer results in the loss of cancer stem cell-like characteristics and a reduced tumor burden
Khalid Abubaker et al.
BMC CANCER (2014)
Cancer Cell Lines for Drug Discovery and Development
Jennifer L. Wilding et al.
CANCER RESEARCH (2014)
Organoid Cultures Derived from Patients with Advanced Prostate Cancer
Dong Gao et al.
CELL (2014)
Therapeutic targeting of constitutive PARP activation compromises stem cell phenotype and survival of glioblastoma-initiating cells
M. Venere et al.
CELL DEATH AND DIFFERENTIATION (2014)
A Collagen-Remodeling Gene Signature Regulated by TGF-β Signaling Is Associated with Metastasis and Poor Survival in Serous Ovarian Cancer
Dong-Joo Cheon et al.
CLINICAL CANCER RESEARCH (2014)
Ovarian tumor-initiating cells display a flexible metabolism
Angela S. Anderson et al.
EXPERIMENTAL CELL RESEARCH (2014)
Exposure of fallopian tube epithelium to follicular fluid mimics carcinogenic changes in precursor lesions of serous papillary carcinoma
K. Bahar-Shany et al.
GYNECOLOGIC ONCOLOGY (2014)
Ovarian cancer stem cells: Molecular concepts and relevance as therapeutic targets
Nuzhat Ahmed et al.
MOLECULAR ASPECTS OF MEDICINE (2014)
Combination cediranib and olaparib versus olaparib alone for women with recurrent platinum-sensitive ovarian cancer: a randomised phase 2 study
Joyce F. Liu et al.
LANCET ONCOLOGY (2014)
Olaparib maintenance therapy in patients with platinum-sensitive relapsed serous ovarian cancer: a preplanned retrospective analysis of outcomes by BRCA status in a randomised phase 2 trial
Jonathan Ledermann et al.
LANCET ONCOLOGY (2014)
The Role of the PTEN/PI3K/Akt Pathway on Prognosis in Epithelial Ovarian Cancer: AMeta-Analysis
Jing Cai et al.
ONCOLOGIST (2014)
Ovarian Cancer Spheroid Cells with Stem Cell-Like Properties Contribute to Tumor Generation, Metastasis and Chemotherapy Resistance through Hypoxia-Resistant Metabolism
Jianqun Liao et al.
PLOS ONE (2014)
Magmas functions as a ROS regulator and provides cytoprotection against oxidative stress-mediated damages
S. Srivastava et al.
CELL DEATH & DISEASE (2014)
Patient-Derived Xenograft Models: An Emerging Platform for Translational Cancer Research
Manuel Hidalgo et al.
CANCER DISCOVERY (2014)
The Impairment of MAGMAS Function in Human Is Responsible for a Severe Skeletal Dysplasia
Cybel Mehawej et al.
PLOS GENETICS (2014)
Recent Concepts of Ovarian Carcinogenesis: Type I and Type II
Masafumi Koshiyama et al.
BIOMED RESEARCH INTERNATIONAL (2014)
Enrichment for Chemoresistant Ovarian Cancer Stem Cells from Human Cell Lines
Jennifer M. Cole et al.
JOVE-JOURNAL OF VISUALIZED EXPERIMENTS (2014)
Targeted disruption of the JAK2/STAT3 pathway in combination with systemic administration of paclitaxel inhibits the priming of ovarian cancer stem cells leading to a reduced tumor burden
Khalid Abubaker et al.
FRONTIERS IN ONCOLOGY (2014)
Milky Spots Promote Ovarian Cancer Metastatic Colonization of Peritoneal Adipose in Experimental Models
Robert Clark et al.
AMERICAN JOURNAL OF PATHOLOGY (2013)
Transformation of the Fallopian Tube Secretory Epithelium Leads to High-Grade Serous Ovarian Cancer in Brca;Tp53;Pten Models
Ruth Perets et al.
CANCER CELL (2013)
New Strategies in the Treatment of Ovarian Cancer: Current Clinical Perspectives and Future Potential
Susana Banerjee et al.
CLINICAL CANCER RESEARCH (2013)
The Stem-Cell Profile of Ovarian Surface Epithelium is Reproduced in the Oviductal Fimbriae, with Increased Stem-Cell Marker Density in Distal Parts of the Fimbriae
Nelly Auersperg
INTERNATIONAL JOURNAL OF GYNECOLOGICAL PATHOLOGY (2013)
Cancer Development, Progression, and Therapy: An Epigenetic Overview
Sibaji Sarkar et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2013)
Cancerous ovarian stem cells: Obscure targets for therapy but relevant to chemoresistance
Nuzhat Ahmed et al.
JOURNAL OF CELLULAR BIOCHEMISTRY (2013)
Short-term single treatment of chemotherapy results in the enrichment of ovarian cancer stem cell-like cells leading to an increased tumor burden
Khalid Abubaker et al.
MOLECULAR CANCER (2013)
Ovarian surface epithelium at the junction area contains a cancer-prone stem cell niche
Andrea Flesken-Nikitin et al.
NATURE (2013)
Cancer stem cells: The challenges ahead
Jan Paul Medema
NATURE CELL BIOLOGY (2013)
Modulation of oxidative stress as an anticancer strategy
Chiara Gorrini et al.
NATURE REVIEWS DRUG DISCOVERY (2013)
Correction: Magmas Overexpression Inhibits Staurosporine Induced Apoptosis in Rat Pituitary Adenoma Cell Lines
Federico Tagliati et al.
PLoS One (2013)
Getting to know ovarian cancer ascites: opportunities for targeted therapy-based translational research
Nuzhat Ahmed et al.
FRONTIERS IN ONCOLOGY (2013)
Ovarian tumor attachment, invasion, and vascularization reflect unique microenvironments in the peritoneum: insights from xenograft and mathematical models
Mara P. Steinkamp et al.
FRONTIERS IN ONCOLOGY (2013)
Meeting the challenge of ascites in ovarian cancer: new avenues for therapy and research
Emma Kipps et al.
NATURE REVIEWS CANCER (2013)
ALDH1-Bright Epithelial Ovarian Cancer Cells Are Associated with CD44 Expression, Drug Resistance, and Poor Clinical Outcome
Yu-Chi Wang et al.
AMERICAN JOURNAL OF PATHOLOGY (2012)
Prognostic significance of tumor-infiltrating T cells in ovarian cancer: A meta-analysis
Wei-Ting Hwang et al.
GYNECOLOGIC ONCOLOGY (2012)
Expression of aldehyde dehydrogenase and CD133 defines ovarian cancer stem cells
Ilona Kryczek et al.
INTERNATIONAL JOURNAL OF CANCER (2012)
Smoothened Antagonists Reverse Taxane Resistance in Ovarian Cancer
Adam D. Steg et al.
MOLECULAR CANCER THERAPEUTICS (2012)
Olaparib Maintenance Therapy in Platinum-Sensitive Relapsed Ovarian Cancer
Jonathan Ledermann et al.
NEW ENGLAND JOURNAL OF MEDICINE (2012)
Identification of a Potential Ovarian Cancer Stem Cell Gene Expression Profile from Advanced Stage Papillary Serous Ovarian Cancer
Vinod Vathipadiekal et al.
PLOS ONE (2012)
Rapid Whole-Genome Sequencing for Genetic Disease Diagnosis in Neonatal Intensive Care Units
Carol Jean Saunders et al.
SCIENCE TRANSLATIONAL MEDICINE (2012)
Ovarian Cancer is an Imported Disease: Fact or Fiction?
Elisabetta Kuhn et al.
CURRENT OBSTETRICS AND GYNECOLOGY REPORTS (2012)
Regulation of Inflammation by the NF-κB Pathway in Ovarian Cancer Stem Cells
Aliza L. Leizer et al.
AMERICAN JOURNAL OF REPRODUCTIVE IMMUNOLOGY (2011)
Design, synthesis, and biological activity of novel Magmas inhibitors
Paul T. Jubinsky et al.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2011)
Aldehyde Dehydrogenase in Combination with CD133 Defines Angiogenic Ovarian Cancer Stem Cells That Portend Poor Patient Survival
Ines A. Silva et al.
CANCER RESEARCH (2011)
Targeting ALDHbright Human Carcinoma-Initiating Cells with ALDH1A1-Specific CD8+ T Cells
Carmen Visus et al.
CLINICAL CANCER RESEARCH (2011)
CD44-Targeting for Antitumor Drug Delivery: A New SN-38-Hyaluronan Bioconjugate for Locoregional Treatment of Peritoneal Carcinomatosis
A. Serafino et al.
CURRENT CANCER DRUG TARGETS (2011)
Indoleamine 2,3-dioxygenase and immune tolerance in ovarian cancer
Kazuhiko Ino
CURRENT OPINION IN OBSTETRICS & GYNECOLOGY (2011)
Long-term Expansion of Epithelial Organoids From Human Colon, Adenoma, Adenocarcinoma, and Barrett's Epithelium
Toshiro Sato et al.
GASTROENTEROLOGY (2011)
The Origin of Ovarian Carcinomas: A Unifying Hypothesis
Nelly Auersperg
INTERNATIONAL JOURNAL OF GYNECOLOGICAL PATHOLOGY (2011)
Cisplatin Treatment of Primary and Metastatic Epithelial Ovarian Carcinomas Generates Residual Cells With Mesenchymal Stem Cell-Like Profile
Ardian Latifi et al.
JOURNAL OF CELLULAR BIOCHEMISTRY (2011)
Olaparib in patients with recurrent high-grade serous or poorly differentiated ovarian carcinoma or triple-negative breast cancer: a phase 2, multicentre, open-label, non-randomised study
Karen A. Gelmon et al.
LANCET ONCOLOGY (2011)
Integrated genomic analyses of ovarian carcinoma
D. Bell et al.
NATURE (2011)
Adipocytes promote ovarian cancer metastasis and provide energy for rapid tumor growth
Kristin M. Nieman et al.
NATURE MEDICINE (2011)
Targeting cancer stem cells by inhibiting Wnt, notch, and Hedgehog pathways
Naoko Takebe et al.
NATURE REVIEWS CLINICAL ONCOLOGY (2011)
Modeling high-grade serous ovarian carcinogenesis from the fallopian tube
Alison M. Karst et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2011)
Histologic, Molecular, and Cytogenetic Features of Ovarian Cancers: Implications for Diagnosis and Treatment
Neeraj Lalwani et al.
RADIOGRAPHICS (2011)
Detection, Characterization, and Spontaneous Differentiation In Vitro of Very Small Embryonic-Like Putative Stem Cells in Adult Mammalian Ovary
Seema Parte et al.
STEM CELLS AND DEVELOPMENT (2011)
Molecular Requirements for Transformation of Fallopian Tube Epithelial Cells into Serous Carcinoma
Amir A. Jazaeri et al.
NEOPLASIA (2011)
Ovarian Cancer Development and Metastasis
Ernst Langyel
AMERICAN JOURNAL OF PATHOLOGY (2010)
In vitro metastatic colonization of human ovarian cancer cells to the omentum
Shaheena M. Khan et al.
CLINICAL & EXPERIMENTAL METASTASIS (2010)
Targeting Hedgehog - a Cancer Stem Cell Pathway
Akil A. Merchant et al.
CLINICAL CANCER RESEARCH (2010)
Epithelial Mesenchymal Transition and Cancer Stem Cell-Like Phenotypes Facilitate Chemoresistance in Recurrent Ovarian Cancer
N. Ahmed et al.
CURRENT CANCER DRUG TARGETS (2010)
Magmas, a Gene Newly Identified as Overexpressed in Human and Mouse ACTH-Secreting Pituitary Adenomas, Protects Pituitary Cells from Apoptotic Stimuli
Federico Tagliati et al.
ENDOCRINOLOGY (2010)
Role of Magmas in protein transport and human mitochondria biogenesis
Devanjan Sinha et al.
HUMAN MOLECULAR GENETICS (2010)
Targeting Aldehyde Dehydrogenase Cancer Stem Cells in Ovarian Cancer
Charles N. Landen et al.
MOLECULAR CANCER THERAPEUTICS (2010)
Defining the role of hypoxia-inducible factor 1 in cancer biology and therapeutics
G. L. Semenza
ONCOGENE (2010)
CD24+ cells from hierarchically organized ovarian cancer are enriched in cancer stem cells
M-Q Gao et al.
ONCOGENE (2010)
Natural immunity to pluripotency antigen OCT4 in humans
Kavita M. Dhodapkar et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2010)
Microenvironment and Pathogenesis of Epithelial Ovarian Cancer
Antonio F. Saad et al.
Hormones & Cancer (2010)
Ovarian Cancer Pathogenesis: A Model in Evolution
Alison M. Karst et al.
JOURNAL OF ONCOLOGY (2010)
Role of Surgical Outcome as Prognostic Factor in Advanced Epithelial Ovarian Cancer: A Combined Exploratory Analysis of 3 Prospectively Randomized Phase 3 Multicenter Trials By the Arbeitsgemeinschaft Gynaekologische Onkologie Studiengruppe Ovarialkarzinom (AGO-OVAR) and the Groupe d'Investigateurs Nationaux Pour les Etudes des Cancers de l'Ovaire (GINECO)
Andreas du Bois et al.
CANCER (2009)
Ovarian Cancer Cell Detachment and Multicellular Aggregate Formation Are Regulated by Membrane Type 1 Matrix Metalloproteinase: A Potential Role in I.p. Metastatic Dissemination
Natalie M. Moss et al.
CANCER RESEARCH (2009)
Molecular phenotyping of human ovarian cancer stem cells unravel the mechanisms for repair and chemo-resistance
Ayesha B. Alvero et al.
CELL CYCLE (2009)
Epidemiologic correlates of ovarian cortical inclusion cysts (CICs) support a dual precursor pathway to pelvic epithelial cancer
Ann K. Folkins et al.
GYNECOLOGIC ONCOLOGY (2009)
Antioxidant and oncogene rescue of metabolic defects caused by loss of matrix attachment
Zachary T. Schafer et al.
NATURE (2009)
An Epigenetic Signature in Peripheral Blood Predicts Active Ovarian Cancer
Andrew E. Teschendorff et al.
PLOS ONE (2009)
Parthenogenetic Embryo-Like Structures in the Human Ovarian Surface Epithelium Cell Culture in Postmenopausal Women with No Naturally Present Follicles and Oocytes
Irma Virant-Klun et al.
STEM CELLS AND DEVELOPMENT (2009)
DNA methylation changes in ovarian cancer are cumulative with disease progression and identify tumor stage
George S. Watts et al.
BMC MEDICAL GENOMICS (2008)
Identification and characterization of ovarian cancer-initiating cells from primary human tumors
Shu Zhang et al.
CANCER RESEARCH (2008)
The epithelial-mesenchymal transition generates cells with properties of stem cells
Sendurai A. Mani et al.
CELL (2008)
Novel molecular subtypes of serous and endometrioid ovarian cancer linked to clinical outcome
Richard W. Tothill et al.
CLINICAL CANCER RESEARCH (2008)
CD44 and EpCAM: Cancer-Initiating Cell Markers
Rachid Marhaba et al.
CURRENT MOLECULAR MEDICINE (2008)
Putative stem cells with an embryonic character isolated from the ovarian surface epithelium of women with no naturally present follicles and oocytes
Irma Virant-Klun et al.
DIFFERENTIATION (2008)
Folate receptor alpha as a tumor target in epithelial ovarian cancer
Kimberly R. Kalli et al.
GYNECOLOGIC ONCOLOGY (2008)
Expression of CD133-1 and CD133-2 in ovarian cancer
G. Ferrandina et al.
INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER (2008)
Pathogenesis of ovarian cancer: Lessons from morphology and molecular biology and their clinical implications
Robert J. Kurman et al.
INTERNATIONAL JOURNAL OF GYNECOLOGICAL PATHOLOGY (2008)
Hyaluronan-CD44 interaction activates stem cell marker Nanog, Stat-3-mediated MDR1 gene expression, and ankyrin-regulated multidrug efflux in breast and ovarian tumor cells
Lilly Y. W. Bourguignon et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2008)
New Insights Into the Pathogenesis of Serous Ovarian Cancer and Its Clinical Impact
Keren Levanon et al.
JOURNAL OF CLINICAL ONCOLOGY (2008)
Normal ovarian surface epithelial label-retaining cells exhibit stem/progenitor cell characteristics
Paul P. Szotek et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2008)
Distinct patterns of structural and numerical chromosomal instability characterize sporadic ovarian cancer
Jane Bayani et al.
NEOPLASIA (2008)
Epithelial-mesenchymal interconversions in normal ovarian surface epithelium and ovarian carcinomas: An exception to the norm
Nuzhat Ahmed et al.
JOURNAL OF CELLULAR PHYSIOLOGY (2007)
Identification of human aldehyde dehydrogenase 1 family member a1 as a novel CD8+ T-Cell-Defined tumor antigen in squamous cell carcinoma of the head and neck
Carmen Visus et al.
CANCER RESEARCH (2007)
Expression of hypoxia-inducible factor 1α, hypoxia-inducible factor 2α, and von Hippel-Lindau protein in epitheLiaL ovarian neoplasms and allelic loss of von Hippel-Lindau gene:: nuclear expression of hypoxia-inducible factor 1α is an independent prognostic factor in ovarian carcinoma
Ryosuke Osada et al.
HUMAN PATHOLOGY (2007)
The Qo site of the mitochondrial complex III is required for the transduction of hypoxic signaling via reactive oxygen species production
Eric L. Bell et al.
JOURNAL OF CELL BIOLOGY (2007)
Greater and lesser omenta: Normal anatomy and pathologic processes
Eunhye Yoo et al.
RADIOGRAPHICS (2007)
AKT mediates the pro-survival effects of KIT in ovarian cancer cells and is a determinant of sensitivity to imatinib mesylate
Tanya J. Shaw et al.
GYNECOLOGIC ONCOLOGY (2007)
A candidate precursor to serous carcinoma that originates in the distal fallopian tube
Y. Lee et al.
JOURNAL OF PATHOLOGY (2007)
The role of constitutively active signal transducer and activator of transcription 3 in ovarian turnorigenesis and prognosis
Daniel G. Rosen et al.
CANCER (2006)
Cytogenetic instability in ovarian epithelial cells from women at risk of ovarian cancer
Tanja Pejovic et al.
CANCER RESEARCH (2006)
Signal transducers and activators of transcription 3 pathway activation in drug-resistant ovarian cancer
Zhenfeng Duan et al.
CLINICAL CANCER RESEARCH (2006)
Ovarian cancer side population defines cells with stem cell-like characteristics and Mullerian Inhibiting Substance responsiveness
Paul P. Szotek et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2006)
Antibody-drug conjugates designed to eradicate tumors with homogeneous and heterogeneous expression of the target antigen
YV Kovtun et al.
CANCER RESEARCH (2006)
The tubal fimbria is a preferred site for early adenocarcinoma in women with familial ovarian cancer syndrome
F Medeiros et al.
AMERICAN JOURNAL OF SURGICAL PATHOLOGY (2006)
CpG island methylation of DNA damage response genes in advanced ovarian cancer
JM Teodoridis et al.
CANCER RESEARCH (2005)
Patterns of gene expression in different histotypes of epithelial ovarian cancer correlate with those in normal fallopian tube, endometrium, and colon
RT Marquez et al.
CLINICAL CANCER RESEARCH (2005)
Role of Pam16's degenerate J domain in protein import across the mitochondrial inner membrane
PR D'Silva et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2005)
Microarray analysis identifies a death-from-cancer signature predicting therapy failure in patients with multiple types of cancer
GV Glinsky et al.
JOURNAL OF CLINICAL INVESTIGATION (2005)
Stem and progenitor-like cells contribute to the aggressive behavior of human epithelial ovarian cancer
SA Bapat et al.
CANCER RESEARCH (2005)
Magmas expression in neoplastic human prostate
PT Jubinsky et al.
JOURNAL OF MOLECULAR HISTOLOGY (2005)
Hypermethylation of the PTEN gene in ovarian cancer cell lines
T Schönorf et al.
CANCER LETTERS (2004)
The J domain-related cochaperone Tim16 is a constituent of the mitochondrial TIM23 preprotein translocase
C Kozany et al.
NATURE STRUCTURAL & MOLECULAR BIOLOGY (2004)
DNA hypomethylation and ovarian cancer biology
M Widschwendter et al.
CANCER RESEARCH (2004)
Recurrent ovarian cancer: How important is it to treat to disease progression?
TJ Herzog
CLINICAL CANCER RESEARCH (2004)
Oxidative damage to DNA of ovarian surface epithelial cells affected by ovulation: Carcinogenic implication and chemoprevention
WJ Murdoch et al.
EXPERIMENTAL BIOLOGY AND MEDICINE (2004)
The anti-angiogenic basis of metronomic chemotherapy
RS Kerbel et al.
NATURE REVIEWS CANCER (2004)
Phase III trial of carboplatin and paclitaxel compared with cisplatin and paclitaxel in patients with optimally resected stage III ovarian cancer: A Gynecologic Oncology Group study
RF Ozols et al.
JOURNAL OF CLINICAL ONCOLOGY (2003)
Developmental expression of magmas in murine tissues and its co-expression with the GM-CSF receptor
PT Jubinsky et al.
JOURNAL OF HISTOCHEMISTRY & CYTOCHEMISTRY (2003)
Prospective identification of tumorigenic breast cancer cells
M Al-Hajj et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2003)
Intratumoral T cells, recurrence, and survival in epithelial ovarian cancer
L Zhang et al.
NEW ENGLAND JOURNAL OF MEDICINE (2003)
Future directions in the treatment of ovarian cancer
RF Ozols
SEMINARS IN ONCOLOGY (2002)
Hypoxia - A key regulatory factor in tumour growth
AL Harris
NATURE REVIEWS CANCER (2002)
Identification and characterization of Magmas, a novel mitochondria-associated protein involved in granulocyte-macrophage colony-stimulating factor signal transduction
PT Jubinsky et al.
EXPERIMENTAL HEMATOLOGY (2001)
Dysplastic changes in prophylactically removed Fallopian tubes of women predisposed to developing ovarian cancer
JMJ Piek et al.
JOURNAL OF PATHOLOGY (2001)
Functional interplay between type I collagen and cell surface matrix metalloproteinase activity
SM Ellerbroek et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2001)
Ovarian surface epithelium: Biology, endocrinology, and pathology
N Auersperg et al.
ENDOCRINE REVIEWS (2001)
Analysis of autopsy evaluations of ovarian cancer patients treated at the National Cancer Institute, 1972-1988
E Reed et al.
AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS (2000)
分享论文
